Sulfamethoxazole + Trimethoprim Suspension Suppliers & Bulk Manufacturers
Available Forms: Suspension
Available Strengths: 80 mg/400 mg per 5 mL, 160 mg/800 mg per 5 mL
Reference Brands: Bactrim(US)
Category:
Antibiotics
Sulfamethoxazole inhibits bacterial folate synthesis, while trimethoprim blocks dihydrofolate reductase, disrupting DNA and protein production. The combination provides broad-spectrum activity, effective against urinary, respiratory, and skin infections. Benefits include rapid bacterial clearance, excellent oral absorption, and convenience for pediatric and outpatient treatment when used properly.
Sulfamethoxazole + Trimethoprim Suspension is available in Suspension
and strengths such as 80 mg/400 mg per 5 mL, 160 mg/800 mg per 5 mL.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Sulfamethoxazole + Trimethoprim Suspension is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Sulfamethoxazole + Trimethoprim Suspension can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Sulfamethoxazole + Trimethoprim suspension is approved in the EU and US for urinary tract, respiratory, and skin infections. In the EU, brands like Bactrim and Septra are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and manufacturing standards. In the US, FDA approval relies on extensive clinical data; generic formulations are available. Both regions require detailed dossiers, including clinical trial results, quality manufacturing practices, and pharmacovigilance plans for approval and ongoing safety monitoring. For regulatory support, dossier preparation, and compliance, visit PharmaTradz. We facilitate seamless market access for sulfamethoxazole + trimethoprim suspension, ensuring adherence to European and US standards for safe, effective antimicrobial therapy.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing